Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cleve Clin J Med. 2001 Jul;68(7):643-8.

Maximizing response to erythropoietin in treating HIV-associated anemia.

Author information

  • 1Department of Medicine, State University of New York, Downstate Medical Center, Brooklyn 11203, USA. oifudu@downstate.edu

Abstract

Anemia, a common complication of HIV infection, is associated with morbidity and shortened survival. HIV-associated anemia can often be corrected with erythropoietin (EPO) therapy, which is safer than blood transfusion. Because the response to erythropoietin may be impaired by a number of treatable factors, all HIV patients with anemia should undergo careful evaluation for these factors. This article reviews evaluation and treatment strategies to maximize response to EPO and thus limit the need for blood transfusion.

PMID:
11453082
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk